Fentanyl and Ketobemidone: Interaction Details
- Fentanyl
- AbstralActiqFentora +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl and Ketobemidone interaction:
Fentanyl
- Abstral
- Actiq
- Fentora
- Onsolis
- Subsys
- Ionsys
Ketobemidone
We don't have a drug information page for Ketobemidone yet. Have a question about Ketobemidone? Ask a pharmacist, free →
What Happens When You Take Fentanyl With Ketobemidone
What can happen when they are taken together (rated Major)
Increased risk of respiratory and and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Using fentaNYL together with a depressant can raise the risk of serotonin syndrome, profound , , , coma, and death. The combination of fentaNYL and CNS depressants should be reserved for patients in whom alternative treatments are inadequate.
When the combination cannot be avoided, the lowest effective dosages and the shortest possible duration of co-administration should be prescribed, with dosages titrated according to clinical response. Patients should be monitored for sedation, respiratory depression, and signs and symptoms of serotonin syndrome, and fentaNYL should be discontinued if serotonin syndrome is suspected.321
When fentaNYL injection is used for postoperative analgesia, begin with a reduced dose and watch patients for signs of respiratory depression, sedation, and hypotension. Fluids and other measures for managing possible hypotension should be kept readily at hand.3
The Fentanyl and Ketobemidone Interaction, Explained
Fentanyl and ketobemidone are both strong pain medicines. Taking them together can make you much sleepier and slow your breathing more than either one alone. Your blood pressure can also drop. Both drugs can also raise , so there is a risk of . Signs include agitation, sweating, shaking, muscle twitching, fast heartbeat, and fever. In serious cases this combination can be dangerous.
This is a well-established interaction, but care teams can manage it by using the lowest effective doses for the shortest time and watching you closely. Please don't change anything on your own. Talk with your pharmacist or doctor about your pain plan.
Mechanism: and ( agonism) plus additive activity. Fentanyl has weak serotonergic effects, and ketobemidone is also reported to have serotonergic properties. This is a interaction, not a PK one.
- Direction: increased effect and toxicity (, respiratory depression, , coma, death, ).
- Severity/evidence: major, established. Onset unspecified.
- Management: reserve for patients with inadequate alternatives. Use the lowest effective doses and shortest durations, and titrate to clinical response. Monitor for sedation, respiratory depression, and serotonin syndrome signs. Discontinue fentanyl if serotonin syndrome is suspected.
- Postoperative use: start with a lower fentanyl injection dose and monitor for respiratory depression, sedation, and hypotension. Keep fluids available for hypotension.
See the 8 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl and Ketobemidone Interact
The likely mechanism
; additive
How to Manage the Fentanyl and Ketobemidone Interaction
Your care team will usually try to avoid combining these two unless other options aren't enough for your pain. If both are needed, they typically:
- Use the lowest effective doses for the shortest time, adjusting based on how you respond.
- Monitor you for sleepiness, slowed breathing, and signs of .
- Stop fentanyl if serotonin syndrome is suspected.
- After surgery, start with a lower fentanyl dose and watch your breathing, alertness, and blood pressure.
Keep taking your medicines exactly as prescribed, and tell your pharmacist or prescriber about all your medicines. Seek urgent help for extreme drowsiness, trouble breathing, confusion, agitation, tremor, or fever.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl or Ketobemidone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
6 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection
Observational studies have shown that using analgesics together with raises the risk of drug-related death relative to opioid analgesic use alone. Since other depressant drugs share similar pharmacological properties, a comparable risk can reasonably be expected when they are used concomitantly with opioid analgesics.321
-
Report 2 · Study title
Case scenario: opioid association with serotonin syndrome: implications to the practitioners
A case report details associated in a 58-year-old man with chronic back pain. He had been stable on treatment for pain and depression, with a regimen of transdermal fentaNYL 75 mcg/hr patches, oxyCODONE 5 mg/acetaminophen 325 mg twice daily, celecoxib 200 mg twice daily, citalopram 40 mg once daily, and mirtazapine 50 mg at night.
He also took doxazosin 4 mg daily and zolpidem 12.5 mg as needed for insomnia. Because he reported inadequate pain control, the fentaNYL patch was changed to be replaced every 2 days instead of every 3 days.
About 1 week after this fentaNYL increase, he reported anxiety, tremulousness, fever, and sweating. CloNIDine 0.2 mg every 4 hours was started, but symptoms did not improve.
Symptoms persisted, and the next day he was given haloperidol and LORazepam for anxiety and agitation. He stopped his fentaNYL patch and, 2 days later, presented to the emergency room with opiate withdrawal.
He was then diagnosed with serotonin syndrome, even though the fentaNYL patch had been discontinued for 30 hours. Haloperidol, fentaNYL, oxyCODONE/acetaminophen, citalopram, and mirtazapine were stopped immediately, and symptoms resolved completely by the following day. Morphine sulfate was prescribed in place of fentaNYL, and citalopram and mirtazapine were restarted, with no recurrence of serotoninergic symptoms at follow-up.4
-
Report 3 · Study title
Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy
associated with fentaNYL given during an esophagogastroduodenoscopy was reported in a 39-year-old woman who was also taking sertraline 100 mg daily as an outpatient. She first presented with hematemesis and had a history of alcoholic cirrhosis.
Before the procedure, an octreotide and pantoprazole drip was begun, and she received 2 doses of fentaNYL 50 micrograms and 2 doses of midazolam 1 mg. After the procedure she became somnolent and extremely rigid in all four extremities, and vecuronium and etomidate were given for immediate intubation.
The rigidity progressed, accompanied by diffuse diaphoresis, horizontal roving eye movements, and a fever of 105 degrees F. Because of the possibility of seizure activity, LORazepam 2 mg IV was given without improvement, and a propofol drip was started for continued during intubation.
A CPK of 2800 units/L and an ammonia level of 340 micromols/L pointed to . A CT scan of the brain excluded an acute intracranial process, and the neurology team diagnosed serotonin syndrome secondary to an interaction between fentaNYL and sertraline.
Propofol was continued for sedation, and she received supportive care with a cooling blanket and cyproheptadine. After 3 days her temperature and CPK level had normalized, and she was later extubated without further complications.5
-
Report 4 · Study title
Serotonin syndrome precipitated by fentanyl during procedural sedation
after IV fentaNYL administration during surgical procedures was reported in 2 patients who were also taking (sertraline and escitalopram). The first patient received IV fentaNYL (50 mcg), midazolam (2 mg), and 2 doses of propofol (60 mg and 40 mg) at an outpatient surgery center before a carpal tunnel release.
After surgery she began shivering and grew increasingly agitated, and was transferred to the emergency department. On presentation she was combative, diaphoretic, confused, unable to follow commands, tachycardic, and hypertensive, with hyperreflexia and ankle clonus.
Creatinine kinase rose to 613 units/L from baseline on hospital day 2. The toxicology service gave escalating doses of without improvement.
She was then intubated and sedated with a continuous propofol infusion. She was extubated after 2 days, all symptoms had resolved by day 3, and she was discharged home.
The second patient was a 59-year-old woman admitted for an omentectomy, who received IV fentaNYL 250 micrograms, etomidate, vecuronium, morphine, and cephazolin. After extubation she became hypoxic and acidotic and was reintubated and transferred to the ICU.
On postoperative day 1 she was extubated, and later became tachycardic and unable to follow commands. On examination she was agitated and diaphoretic, with patellar hyperreflexia and bilateral 3 to 4 beat ankle clonus.
Laboratory evaluation showed a peak creatine kinase of 1161 units/L on postoperative day 2. She was treated with LORazepam and cyproheptadine, and symptoms resolved after 3 days.6
-
Report 5 · Study title
Serotonin toxicity caused by an interaction between fentanyl and paroxetine
A case of postoperative after fentaNYL use for general anesthesia and postoperative analgesia was reported in a 60-year-old woman also receiving PARoxetine. Her outpatient medications were limited to PARoxetine and thyroxine, for depression and hypothyroidism.
She was admitted for extensive resection of a recurrent left chest wall myxofibrosarcoma and was given propofol and 200 mcg of fentaNYL to induce anesthesia. She received a further 800 mcg of fentaNYL intraoperatively (intermittent 50 mcg boluses) and then a fentaNYL infusion (100 to 200 mcg/hr) for postoperative and analgesia (2545 mcg of fentaNYL over 36 hours).
The infusion was continued for 36 hours postoperatively, at which point neurological examination showed intermittent agitation, bilateral hypertonia and hyperreflexia, and bilateral inducible ankle clonus. Symptoms were more severe in the lower limbs and on the right side of the body.
A CT scan of the brain was unremarkable, and all other findings, including a thyroid function test, were within normal limits except for elevated blood pressure (180/90 mmHg), which resolved spontaneously 24 hours after the procedure. fentaNYL was stopped, and 24 hours later neurological symptoms had improved markedly, with complete recovery by postoperative day 4. She was ultimately discharged home without further complications.7
-
Report 6 · Study title
Serotonin syndrome caused by interaction between citalopram and fentanyl
A 65-year-old woman treated with citalopram for depression developed after a fentaNYL patch was started. She had recently been diagnosed with myelodysplastic/myeloproliferative disease, and her regular medications included RABEprazole, tolterodine, HYDROcodone, and over-the-counter .
She was hospitalized with abdominal pain and worsening back pain, and a spontaneous retroperitoneal was found. During hospitalization her worsening back pain was treated with a fentaNYL transdermal patch (25 mcg/hr).
Within 24 hours of starting fentaNYL, she progressively developed increasing confusion, agitation, combativeness, upper extremity tremors, myoclonic jerks, hyperreflexia, and unsteady gait, consistent with serotonin syndrome. (110 to 120 beats per minute) was also noted.
A CT scan and laboratory values showed no abnormalities. fentaNYL was discontinued, and all symptoms resolved within 24 to 36 hours. Symptoms did not recur when oxyCODONE was started for the back pain. Based on the Naranjo adverse event probability scale, the link between this serotonin syndrome and of fentaNYL and citalopram was judged probable.8
Fentanyl and Ketobemidone: Common Questions
How serious is the Fentanyl and Ketobemidone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl and Ketobemidone interaction managed?
Your care team will usually try to avoid combining these two unless other options aren't enough for your pain. If both are needed, they typically: Use the lowest effective doses for the shortest time, adjusting based on how you respond. Monitor you for sleepiness, slowed breathing, and signs of . Stop fentanyl if serotonin syndrome is suspected. After surgery, start with a lower… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Fentanyl with Ketobemidone?
The interaction record says a different medicine may be considered in place of one of these two.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Ask About the Fentanyl and Ketobemidone Interaction
Ask in your own words about taking Fentanyl and Ketobemidone together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (8)
- Product Information: FENTORA® buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2025.
- Product Information: ACTIQ® oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2025. DailyMed
- Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Rising Pharma Holdings, Inc. (per FDA), East Brunswick, NJ, 2025. DailyMed
- Rastogi R, Swarm RA, & Patel TA: Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115(6):1291-1298. PubMed
- Alkhatib AA, Peterson KA, & Tuteja AK: Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 2010; 55(1):215-216. PubMed
- Kirschner R & Donovan JW: Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 2010; 38(4):477-480. DOI
- Rang ST, Field J, & Irving C: Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 2008; 55(8):521-525. PubMed
- Ailawadhi S, Sung KW, Carlson LA, et al: Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007; 32(2):199-202. PubMed
Other Serious Interactions of Fentanyl and Ketobemidone
Also serious with Fentanyl
- IsocarboxazidContraindicated
- LevoketoconazoleContraindicated
- NaltrexoneContraindicated
- PhenelzineContraindicated
Also serious with Ketobemidone
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fentanyl
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 222 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.